Evolent Health is exploring a sale after receiving interest, Reuters reports, citing unidentified people familiar with the matter.
- Potential bidders include
Elevance Health and private equity firmsTPG ,CD&R andKKR - A deal could be reached in the next few weeks
- Evolent is working with a financial adviser on the sale process and has received initial bids
- Evolent, TPG, CD&R, KKR and Elevance did not immediately respond to Reuters’ requests for comment
- Evolent Health shares rise much as 13.6%
To contact the reporter on this story:
To contact the editors responsible ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.
